Skip to main content
SpringerLink
Log in

Therapeutics of X-linked hypophosphatemic rickets

  • Practical Pediatric Nephrology
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

X-linked hypophosphatemia, the most common form of familial rickets, is conventionally treated with 1,25-dihydroxyvitamin D3 (5–50 ng/kg per day) plus phosphate supplementation (70–100 mg/kg per day). However, nephrocalcinosis is noted in many children treated with this therapy. Whether to treat or not and whether such treatment should be continued into adulthood or in pregnancy are unsettled questions. This article reviews these controversies and provides current recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rasmussen H, Tenenhouse HS (1989) Hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw Hill, New York, pp 2581–2604

    Google Scholar 

  2. Bell NH (1985) Vitamin D-endocrine system. J Clin Invest 76:1–6

    PubMed  Google Scholar 

  3. Glorieux FH, Scriver CR, Holick MF, DeLuca HF (1973) X-linked hypophosphatemic rickets: inadequate therapeutic response to 1,25 dihydroxycholecalciferol. Lancet II:287–289

    Google Scholar 

  4. Brickman AS, Coburn JW, Kurokawa K, Bethune JE, Harrison HE, Norman AW (1973) Actions of 1,25 dihydroxycholecalciferol in patients with hypophosphatemic rickets. N Engl J Med 289: 495–498

    PubMed  Google Scholar 

  5. Hirschman GH, DeLuca HF, Chan JCM (1978) Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25-dihydroxyvitamin D3, phosphate, and ascorbic acid. Pediatrics 61:451–457

    PubMed  Google Scholar 

  6. Chan JCM, Bartter FC (1979) Hypophosphatemic rickets: effect of 1-α-25-dihydroxyvitamin-D3 on growth and mineral metabolism. Pediatrics 64:488–495

    PubMed  Google Scholar 

  7. Chan JCM, Lovinger RD, Mamunes P (1980) Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin D3. Pediatrics 66:445–454

    PubMed  Google Scholar 

  8. Glorieux FH, Marie PJ, Pettefore JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303: 1023–1031

    PubMed  Google Scholar 

  9. Rasmussen H, Pechet M, Anast C, Mazur A, Gertner J, Broadus AE (1981) Long term treatment of familial hypophosphatemic rickets with oral phosphate and 1α-hydroxyvitamin D3. J Pediatr 99:16–25

    PubMed  Google Scholar 

  10. Lyles VW, Harrelson JM, Drezner MK (1982) The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia. J Clin Endocrinol Metab 54:307–315

    PubMed  Google Scholar 

  11. Alon U, Chan JCM (1985) The effects of hydrochlorothiazide and amiloride in renal hypophosphatemic rickets. Pediatrics 75: 754–763

    PubMed  Google Scholar 

  12. Alon U, Chan JCM (1984) Effects of PTH and 1,25(OH)2D3 on tubular handling of phosphate in hypophosphatemic rickets. J Clin Endocrinol Metabol 58:671–675

    Google Scholar 

  13. Tsuru N, Chan JCM, Chinchilli VM (1987) Renal hypophosphatemic rickets. Growth and mineral metabolism after treatment with 1,25-dihydroxyvitamin D and phosphate supplementation. Am J Dis Child 141:108–110

    PubMed  Google Scholar 

  14. Stendijk JKR, Hauspier C (1992) Pattern of growth and growth retardation of patients with hypophosphatemic vitamin D resistant rickets: a longitudinal study. Eur J Pediatr 151:422–427

    PubMed  Google Scholar 

  15. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843–1848

    PubMed  Google Scholar 

  16. Balsan S, Tieder M (1990) Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height. J Pediatr 116:365–371

    PubMed  Google Scholar 

  17. Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JHH, Brodehl J (1990) X-linked hypophosphatemia: treatment, height, gain and nephrocalcinosis. Arch Dis Child 65:1125–1128

    PubMed  Google Scholar 

  18. Smith R, Newman RJ, Radda GK, Stokes M, Young A (1984) Hypophosphatemic osteomalacia and myopathy: studies with nuclear magnetic resonance spectroscopy. Clin Sci 67:505–509

    PubMed  Google Scholar 

  19. Econs MJ, Samsa GP, Monger M, Drezner MK, Feussner JR (1992) Frequent misdiagnosis of X-linked hypophosphatemic rickets. J Bone Miner Res 7:S336

    Google Scholar 

  20. Clark CD, Kainer G, Conway WF, Chan JCM (1990) Intramyocellular phosphate metabolism in X-linked hypophosphatemia. J Pediatr 116:288–292

    PubMed  Google Scholar 

  21. Chan JCM, Alon U, Hirschman GH (1985) Renal hypophosphatemic rickets: medical progress. J Pediatr 106:533–544

    PubMed  Google Scholar 

  22. Alon U, Brewer WH, Chan JCM (1983) Nephrocalcinosis: detection by ultrasonography. Pediatrics 71:970–973

    PubMed  Google Scholar 

  23. Goodyer PR, Kronick JB, Jequier S, Reade TM, Scriver CR (1987) Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr 111:700–704

    PubMed  Google Scholar 

  24. Stickler GB, Morgenstern BZ (1989) Hypophosphatemic rickets: final height and clinical symptoms in adults. Lancet II:902–905

    Google Scholar 

  25. Hoyer PF, Reusz GS, Latta K, Feickert HJ, Brodehl J (1990) Die Bedeutung der Sonographie für die Therapie der familiären hypophosphatämischen Vitamin D resistenten Rachitis. In: Gebhardt I, Hackeloer B-J, Klinggräff G, von Seitz K (eds) Ultraschalldiagnostik '89. Springer, New York Berlin Heidelberg, pp 439–441

    Google Scholar 

  26. Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK (1985) Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. J Clin Invest 75:1858–1868

    PubMed  Google Scholar 

  27. Hardy DC, Murphy WA, Siegel BA, Reid IR, Whyte MP (1989) X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology 171:403–414

    PubMed  Google Scholar 

  28. Reusz GS, Latta K, Hoyer PF, Byrd DJ, Ehrich JHH, Brodehl J (1990) Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis and phosphate treated hypophosphatemic rickets. Lancet 335: 1240–1243

    PubMed  Google Scholar 

  29. Alon U, Donaldson DL, Hellerstein S, Warady BA, Harris DJ (1992) Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse. J Pediatr 120:899–905

    PubMed  Google Scholar 

  30. Frost HM (1963) A unique histological feature of vitamin D resistant rickets observed in four cases. Acta Orthop Scand 33:220–226

    PubMed  Google Scholar 

  31. Steendijk R, Moofa VD, Nielsen HKL (1965) Lesion of the bone matrix in vitamin D-resistant rickets. Nature 207:426–427

    PubMed  Google Scholar 

  32. Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L (1992) Defective bone formation by Hyp mouse bone cells transplanted into normal mice: evidence in favor of an intrinsic osteoblast defect. J Bone Miner Res 7:215–220

    PubMed  Google Scholar 

  33. Hanna JD, Niimi K, Chan JCM (1991) X-linked hypophosphatemia. Am J Dis Child 145:865–870

    PubMed  Google Scholar 

  34. Caverzasio J, Montessuit C, Bonjour JP (1960) Stimulatory effect of insulin-like growth factor-1 on renal Pi transport and plasma 1,25-dihydroxyvitamin D3. Endocrinology 127:453–459

    Google Scholar 

  35. Wilson DM, Lee PDK, Morris AM, Reiter EO, Gertner JM, Marcus R, Quarmby VE, Rosenfeld RG (1991) Growth hormone therapy in hypophosphatemic rickets. Am J Dis Child 145:1165–1170

    PubMed  Google Scholar 

  36. Seow KW, Romaniuk K, Sclavos S (1989) Micromorphologic features of dentin in vitamin D-resistant rickets: correlation with clinical grading of severity. Pediatr Dent 11:203–208

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology Division, Department of Pediatrics, Children's Medical Center, Virginia Commonwealth University's Medical College of Virginia, Box 498, 23298-0498, Richmond, Virginia, USA

    Kay Latta, Satoshi Hisano & James C. M. Chan

Authors
  1. Kay Latta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satoshi Hisano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James C. M. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Latta, K., Hisano, S. & Chan, J.C.M. Therapeutics of X-linked hypophosphatemic rickets. Pediatr Nephrol 7, 744–748 (1993). https://doi.org/10.1007/BF01213343

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01213343

Key words

Search

Navigation